Deficiency of LMP10 Attenuates Diet-Induced Atherosclerosis by Inhibiting Macrophage Polarization and Inflammation in Apolipoprotein E Deficient Mice

Frontiers in Cell and Developmental Biology
Jiawei LiaoHui-Hua Li

Abstract

Macrophage polarization and inflammation are key factors for the onset and progression of atherosclerosis. The immunoproteasome complex consists of three inducible catalytic subunits (LMP2, LMP10, and LMP7) that play a critical role in the regulation of these risk factors. We recently demonstrated that the LMP7 subunit promotes diet-induced atherosclerosis via inhibition of MERTK-mediated efferocytosis. Here, we explored the role of another subunit of LMP10 in the disease process, using ApoE knockout (ko) mice fed on an atherogenic diet (ATD) containing 0.5% cholesterol and 20% fat for 8 weeks as an in vivo atherosclerosis model. We observed that ATD significantly upregulated LMP10 expression in aortic lesions, which were primarily co-localized with plaque macrophages. Conversely, deletion of LMP10 markedly attenuated atherosclerotic lesion area, CD68+ macrophage accumulation, and necrotic core expansion in the plaques, but did not change plasma metabolic parameters, lesional SM22α+ smooth muscle cells, or collagen content. Myeloid-specific deletion of LMP10 by bone marrow transplantation resulted in similar phenotypes. Furthermore, deletion of LMP10 remarkably reduced aortic macrophage infiltration and increased M2/M1 ratio, a...Continue Reading

References

Apr 1, 1995·Current Opinion in Cell Biology·M Hochstrasser
Apr 18, 1998·Proceedings of the National Academy of Sciences of the United States of America·A Ciechanover, A L Schwartz
Jan 14, 1999·The New England Journal of Medicine·R Ross
Dec 12, 2002·Journal of the American College of Cardiology·Joerg HerrmannAmir Lerman
Mar 21, 2003·The American Journal of Cardiology·David HarrisonHelmut Drexler
Jun 17, 2006·Arteriosclerosis, Thrombosis, and Vascular Biology·Daniele VersariAmir Lerman
May 16, 2009·Arteriosclerosis, Thrombosis, and Vascular Biology·Zhaoqing YangTimothy A McCaffrey
Aug 21, 2009·Basic Research in Cardiology·Jozef Leo Van HerckArnold G Herman
May 3, 2011·Cell·Kathryn J Moore, Ira Tabas
Dec 29, 2011·Frontiers in Bioscience (Landmark Edition)·Arkhjamil AngelesHonglin Luo
Apr 21, 2012·Arteriosclerosis, Thrombosis, and Vascular Biology·Nicola WilckAntje Ludwig
Dec 12, 2012·Current Opinion in Immunology·Michael BaslerMarcus Groettrup
Aug 7, 2013·Molecular Cancer·Bastian Hoesel, Johannes A Schmid
Sep 3, 2013·Nature Reviews. Immunology·Kathryn J MooreEdward A Fisher
Jul 8, 2014·Circulation Journal : Official Journal of the Japanese Circulation Society·Federica De PaoliGiulia Chinetti-Gbaguidi
Dec 17, 2014·Frontiers in Immunology·Nan WangKe Zen
Dec 21, 2014·Journal of Molecular and Cellular Cardiology·Nan LiHui-Hua Li
Feb 20, 2016·Circulation Research·Ira Tabas, Karin E Bornfeldt
Mar 19, 2016·Cell Death and Differentiation·S ChenT Stoeger
Apr 8, 2017·International Journal of Molecular Sciences·Nicola WilckAntje Ludwig
May 10, 2017·Biochemical and Biophysical Research Communications·Wen YanHui-Hua Li
Feb 21, 2018·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Xian-Yun QinYing Liu
Jun 5, 2018·Current Opinion in Toxicology·Krithika Lingappan
Jul 15, 2018·Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology·Ying ZhangJiawei Liao

❮ Previous
Next ❯

Methods Mentioned

BETA
ubiquitination
flow cytometry
dissecting
Assay
protein assay
PCR

Software Mentioned

Prism

Related Concepts

Related Feeds

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.